HIV Research & Clinical Practice, Volume 17, Issue 1 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

HIV Clinical Trials, Volume 17, Issue 1 (2016)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Volume 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 2000
Download citations Download PDFs Download issue

Original Articles

Article
Time to Viremia for Patients Taking their First Antiretroviral Regimen and the Subsequent Resistance Profiles
Frederic Crouzat, Anita C. Benoit, Colin Kovacs, Graham Smith, Nathan Taback, Ina Sandler, Megan Acsai, William Barrie, Jason Brunetta, Benny Chang, David Fletcher, David Knox, Barry Merkley, Malika Sharma, David Tilley & Mona Loutfy
Pages: 1-11
Published online: 29 Jan 2016
AbstractforTime to Viremia for Patients Taking their First Antiretroviral Regimen and the Subsequent Resistance Profiles | Full Text | References | PDF (744.2 KB)
  • 312 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia
Pornpimol Thamrongwonglert, Ploenchan Chetchotisakd, Siriluck Anunnatsiri & Piroon Mootsikapun
Pages: 12-16
Published online: 07 Jan 2016
AbstractforImprovement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemia | Full Text | References | PDF (230.7 KB)
  • 616 Views
  • 19 CrossRef citations
  • 0Altmetric
Free Access
Article
Long-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study
Eugénio Teófilo, Nuno Rocha-Pereira, Birger Kuhlmann, Antonio Antela, Heribert Knechten, Jesús Santos, Maria Jesús Jiménez-Expósito, on behalf of the REMAIN study group & on behalf of the REMAIN study group
Pages: 17-28
Published online: 05 Feb 2016
AbstractforLong-Term Efficacy, Tolerability, and Renal Safety of Atazanavir/Ritonavir-based Antiretroviral Therapy in a Cohort of Treatment-Naïve Patients with HIV-1 Infection: the REMAIN Study | Full Text | References | PDF (501.9 KB)
  • 1058 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study
Danielle P. Porter, Jonathan Toma, Yuping Tan, Owen Solberg, Suqin Cai, Rima Kulkarni, Kristen Andreatta, Yolanda Lie, Susan K. Chuck, Frank Palella, Michael D. Miller & Kirsten L. White
Pages: 29-37
Published online: 29 Jan 2016
AbstractforClinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study | Full Text | References | PDF (516.5 KB)
  • 760 Views
  • 21 CrossRef citations
  • 0Altmetric
Free Access
Article
Dual Raltegravir–Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors
Leonardo Calza, Ilaria Danese, Eleonora Magistrelli, Vincenzo Colangeli, Roberto Manfredi, Isabella Bon, Maria Carla Re, Matteo Conti & Pierluigi Viale
Pages: 38-47
Published online: 05 Jan 2016
AbstractforDual Raltegravir–Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors | Full Text | References | PDF (349.1 KB)
  • 659 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Explore articles